Carl Zeiss Meditec AGXSWX:AFX 79 Dividend Yield % is 2.03% as of Jun. 24, 2026, which is 121% above its 10-year median of 0.92. GuruFocus rates XSWX:AFX with a GF Score™ of 79/100 and a GF Value™ of CHF67.74 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 327 Medical Devices & Instruments companies, Carl Zeiss Meditec AG ranks better than 51.07% on this metric.
As of today (2026-06-24), the Trailing Annual Dividend Yield of Carl Zeiss Meditec AG is 2.03%.
The historical rank and industry rank for Carl Zeiss Meditec AG's Dividend Yield % or its related term are showing as below:
XSWX:AFX'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.27 Med: 0.92 Max: 2.55
Current: 2.03
During the past 13 years, the highest Dividend Yield of Carl Zeiss Meditec AG was 2.55%. The lowest was 0.27%. And the median was 0.92%.
XSWX:AFX's Dividend Yield % is ranked better than 51.07% of 327
companies
in the Medical Devices & Instruments industry
Industry Median: 1.98
vs XSWX:AFX: 2.03
During the past 12 months, Carl Zeiss Meditec AG's average Dividends Per Share Growth Rate was -45.50% per year.
During the past 3 years, the average Dividends Per Share Growth Rate was -12.60% per year.
During the past 5 years, the average Dividends Per Share Growth Rate was 6.40% per year.
During the past 10 years, the average Dividends Per Share Growth Rate was 9.60% per year.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Carl Zeiss Meditec AG was 30.50% per year. The lowest was -12.60% per year. And the median was 13.10% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Carl Zeiss Meditec AG (XSWX:AFX) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
Carl Zeiss Meditec AG Dividend Yield % Related Terms
Carl Zeiss Meditec AG Dividend Yield % Historical Data
* Premium members only.
The historical data trend for Carl Zeiss Meditec AG's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XSWX:AFX vs ISRG, BDX, MDLN: Dividend Yield % Comparison
For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Carl Zeiss Meditec AG Dividend Yield % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Carl Zeiss Meditec AG's Dividend Yield % falls into.
Carl Zeiss Meditec AG Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Carl Zeiss Meditec AG Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 0.550000
2026-03-27
2026-03-30
2026-03-31
Cash Dividend
annually
EUR:CHF 0.942080
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Carl Zeiss Meditec AG's Trailing Annual Dividend Yield (%) for Today is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Carl Zeiss Meditec AG (XSWX:AFX) has a Dividend Yield % of 2.03% as of Jun. 24, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Carl Zeiss Meditec AG and its competitors. This is 121% above median its historical median of 0.92. Over the past decade, Carl Zeiss Meditec AG's Dividend Yield % has ranged from 0.27 to 2.55. According to the industry distribution chart, Carl Zeiss Meditec AG ranks #160 out of 327 companies in the Medical Devices & Instruments industry, placing it in the top 48.9%.
Is Carl Zeiss Meditec AG's Dividend Yield % too high?
Carl Zeiss Meditec AG's current Dividend Yield % of 2.03% is 121% above median its 10-year median of 0.92. Over the past 10 years, this metric has ranged from a low of 0.27 to a high of 2.55. The Medical Devices & Instruments industry median Dividend Yield % is 1.98. Carl Zeiss Meditec AG's value of 2.03% is 2.5% above this industry median. Based on the distribution chart, Carl Zeiss Meditec AG ranks #160 out of 327 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Carl Zeiss Meditec AG has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Carl Zeiss Meditec AG's Dividend Yield % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Carl Zeiss Meditec AG ranks #160 out of 327 companies for Dividend Yield %. This puts Carl Zeiss Meditec AG in the upper half of its industry. The industry median Dividend Yield % is 1.98. Carl Zeiss Meditec AG's value of 2.03% is 2.5% above this benchmark. Historically, Carl Zeiss Meditec AG's own Dividend Yield % has ranged from 0.27 to 2.55 over the past decade. While the company's 10-year median is 0.92 vs. the industry median of 1.98, Carl Zeiss Meditec AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Devices & Instruments company?
The median Dividend Yield % among Medical Devices & Instruments companies is 1.98, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Carl Zeiss Meditec AG's current Dividend Yield % of 2.03% is 2.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Carl Zeiss Meditec AG and its competitors. For the Medical Devices & Instruments industry, the median Dividend Yield % is 1.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Carl Zeiss Meditec AG's current Dividend Yield % is 2.03%, which is 121% above median its own 10-year median of 0.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Carl Zeiss Meditec AG stock overvalued right now?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG (XSWX:AFX) is currently considered Significantly Undervalued. The stock's GF Value™ is CHF67.74, compared to a current price of CHF24.80 — trading 63.4% below its estimated fair value. The current Dividend Yield % is 2.03%, which is 121% above median its 10-year median of 0.92 and 2.5% above the Medical Devices & Instruments industry median of 1.98. Carl Zeiss Meditec AG's overall GF Score™ is 79/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Carl Zeiss Meditec AG (XSWX:AFX), the current Dividend Yield % is 2.03% as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Carl Zeiss Meditec AG (XSWX:AFX) Overvalued in 2026?
Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued.
The current stock price of CHF24.80 is trading 63.4% below its estimated GF Value™ of CHF67.74.
GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.
Key valuation signals for XSWX:AFX:
Dividend Yield %: 2.03% (121% above median its 10-year median of 0.92)
GF Value™: CHF67.74 vs. price of CHF24.80 (63.4% below fair value)
Industry Position: 2.5% above the Medical Devices & Instruments median (#160 of 327)
No single metric tells the full story. See the XSWX:AFX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
79GF Score
Get the complete analysis for XSWX:AFX
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XSWX:AFX has been successfully added to your 
